Categories Consumer, Health Care, U.S. Markets News

Earnings preview: Strong Q4 results might lift UnitedHealth Group’s stock

UnitedHealth Group (UNH) is scheduled to report fourth-quarter 2018 earnings results on Tuesday, January 15. Analysts expect the company to report earnings of $3.22 per share on revenue of $57.9 billion. The company has beaten estimates consistently over the past four quarters and can be expected to continue the trend.

In the third quarter, UnitedHealth topped estimates for both revenue and earnings and raised its full-year outlook. Revenues grew 12.4% year-over-year to $56.6 billion, driven by strength in the UnitedHealthcare and Optum segments. Adjusted EPS grew 28% to $3.41.

The UnitedHealthcare segment saw a 12.8% increase in total revenue helped by growth in customers and higher pricing. All the divisions in this segment delivered revenue growth. The Optum segment posted an 11% growth in total revenue broadbased across all its divisions helped by growth and expansion in products and services.

UnitedHealth Group boosted by solid Q3 results and updated outlook

United is likely to see growth in segment revenues for the fourth quarter as well. The company secured contract wins for both its business units during the quarter. Two key metrics to watch out for are medical costs and medical care ratio. For the first three quarters of 2018, medical costs have continued to increase and in the third quarter, it amounted to $36.1 billion. Medical care ratio declined 40 basis points to 81% last quarter.

For full-year 2018, United has guided for GAAP EPS of $12.10 and adjusted EPS of $12.80. Over the past one month, United’s stock has dropped over 8%. If the company beats estimates, the stock could see a gain. As of 1:05 pm ET, the stock was up 0.8%.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top